Northeast Oncology Associates Suite 250 — Concord, North Carolina

Northeast Oncology Associates Suite 250 is a clinical research site located in Concord, North Carolina, United States 28025.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Northeast Oncology Associates Suite 250 has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Oncology Associates Suite 250?

Northeast Oncology Associates Suite 250 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Oncology Associates Suite 250 conducted?

Northeast Oncology Associates Suite 250 has 1 clinical trials on record. Their work covers Breast Cancer.

Is Northeast Oncology Associates Suite 250 accredited by Crixeo Health?

Northeast Oncology Associates Suite 250 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Oncology Associates Suite 250?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.